Mitochondrial Dysfunction

R&D

Partner Content

4th Mitochondrial Dysfunction Drug Development Summit

Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success

Events

Copy of Bella Mitochondria-Targeted Drug Development - LinkedIn (2)

Partner Content

2nd Mitochondria-Targeted Drug Development Summit

Therapies for mitochondrial dysfunction

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Mitochondrial Dysfunction

Editor's Picks